Aytu BioPharma Strengthens Leadership Team with Appointment of Richard Eisenstadt as Chief Financial OfficerAccesswire • 04/05/21
Aytu BioScience: The Moonshot Continues To Orbit Awaiting The Next Giant StepsSeeking Alpha • 03/14/21
Aytu Bioscience, Inc. (AYTU) Moves 9.2% Higher: Will This Strength Last?Zacks Investment Research • 03/12/21
Aytu BioScience Stock Is Trading Higher After Healight Therapy Shows Improved Outcome In COVID-19 PatientsBenzinga • 03/09/21
Aytu BioScience Announces Positive Clinical Results from Healight(TM) Pilot Study in SARS-CoV-2 PatientsAccesswire • 03/08/21
Aytu BioScience, Inc. (AYTU) CEO Joshua Disbrow on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/12/21
Aytu BioScience Announces Completion of Healight(TM) Safety Study in Critically Ill COVID-19 PatientsAccesswire • 12/28/20
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc.PRNewsWire • 12/11/20
Merger Thursday: Gilead Buys German Drug Company, Aytu-Neos All-Stock Deal, Boehringer Picks Up NBE-TherapeuticsBenzinga • 12/10/20